IDiyas

For the Inventor, By the Inventor

Yokohama, Japan

Shigeharu Inoue

USPTO Granted Patents = 12

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Yokohama, JA (1978)
  • Yokohama, JP (1979 - 1994)

Company Filing History:

goldMedal12 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents
silverMedal1 out of 212 
 
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai
 patents
where one patent can have more than one assignee

Years Active: 1978-1994

Loading Chart...
12 patents (USPTO):
1. 5332731 - Cephalosporin derivatives (1994-07-26),
2. 5294705 - Process for the preparation of a 3-substituted thio-3-cephem compound (1994-03-15),
3. 5206384 - Actinonin derivatives and pharmaceutically acceptable salts thereof (1993-04-27),
4. 4785090 - Cephalosporin derivatives (1988-11-15),
5. 4758557 - Cephalosporin derivatives and bactericides containing the same (1988-07-19),
6. 4357331 - 7.alpha.Methoxycephalosporin derivatives (1982-11-02),
7. 4242327 - Antibiotic SF-2052 substance and production and use thereof (1980-12-30),
8. 4169140 - Antibiotics SF-1771 substance and SF-1771-B substance as well as the (1979-09-25),
9. 4160026 - Antibiotics SF-1130-x.sub.1 and -x.sub.2 substances and production and (1979-07-03),
10. 4156728 - 3-Substituted-2(1H)pyridone-6-carboxylic acids (1979-05-29),
11. 4151041 - Process for production of maltopentaose and maltohexaose (1979-04-24),
12. 4083850 - 3-Substituted-2(1H)pyridon-6-carboxylic acids and process for (1978-04-11),

Title: Shigeharu Inoue: A Pioneer in Antibacterial Innovations

Introduction

Shigeharu Inoue is a notable inventor based in Yokohama, Japan, recognized for his significant contributions to the field of antibacterial agents. With a total of 12 patents to his name, Inoue has made remarkable advancements in pharmaceutical chemistry, particularly in the development of cephalosporin derivatives.

Latest Patents

One of Inoue's latest patents involves a new class of cephalosporin derivatives, which are particularly useful as antibacterial agents suitable for oral administration in mammals, including humans. This innovation is represented by a general formula that includes various substituents, allowing for effective treatment options. Additionally, he has developed a process for the preparation of a 3-substituted thio-3-cephem compound, further enhancing the arsenal of antibacterial agents available for medical use.

Career Highlights

Throughout his career, Inoue has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and the Biseibutsu Kagaku Kenkyu Kai Foundation. His work in these organizations has allowed him to focus on research and development in the pharmaceutical sector, leading to his numerous patents and innovations.

Collaborations

Inoue has collaborated with esteemed colleagues, including Takashi Tsuruoka and Katsuyoshi Iwamatsu. These partnerships have contributed to the advancement of his research and the successful development of new antibacterial compounds.

Conclusion

Shigeharu Inoue's contributions to the field of antibacterial agents through his innovative patents and collaborations highlight his importance as an inventor. His work continues to impact the pharmaceutical industry positively, paving the way for new treatments and advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…